NDC 59572-711-01 Reblozyl
Luspatercept
NDC Package Code 59572-711-01
The NDC Code 59572-711-01 is assigned to a package of 1 vial, glass in 1 carton > 1 injection, powder, lyophilized, for solution in 1 vial, glass of Reblozyl, a human prescription drug labeled by Celgene Corporation. The product's dosage form is injection, powder, lyophilized, for solution and is administered via subcutaneous form.This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package.
NDC Code Structure
- 59572 - Celgene Corporation
- 59572-711 - Reblozyl
- 59572-711-01 - 1 VIAL, GLASS in 1 CARTON
- 59572-711 - Reblozyl
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the disclaimer below.
NDC HCPCS Crosswalk
This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.
NDC 59572-711-01 HCPCS crosswalk information with package details and bill units information.
NDC Billing Code | HCPCS Code | HCPCS Code Desc. | Dosage | Package Size | Package Quantity | Billable Units | Billable Units / Pkg |
---|---|---|---|---|---|---|---|
59572071101 | J0896 | Inj luspatercept-aamt 0.25mg | 0.25 MG | 1 | 1 | 100 | 100 |
* Please review the disclaimer below.